Tuberculosis bacteria stiffen cell membranes to evade immune destruction

Scientists have identified a novel mechanism employed by tuberculosis-causing bacteria to survive within human cells, a finding that could reshape strategies for combating this global health threat. Tuberculosis, caused by mycobacteria, continues to be a major public health crisis, resulting in over a million deaths annually, particularly in Asia, Africa, and Latin America.

A Hidden Defense Mechanism

The research, slated for presentation at the 70th Biophysical Society Annual Meeting in San Francisco from February 21–25, 2026, and recently posted on bioRxiv, details how mycobacteria utilize tiny packages called extracellular vesicles. These vesicles fuse with the membranes of human immune cells, altering their properties.

Normally, immune cells engulf bacteria, trapping them within a compartment called a phagosome. This phagosome then merges with a lysosome, which contains enzymes that destroy the bacteria. However, the study reveals that mycobacteria stiffen the phagosome membrane, preventing this crucial fusion. This effectively creates a protective barrier, allowing the bacteria to evade destruction.

The Role of Lipids

“If the membrane becomes more rigid, it becomes much harder for the phagosome to fuse with the lysosome,” explained Ayush Panda, formerly a graduate student in the laboratory of Mohammed Saleem at the National Institute of Science Education and Research, India. “It’s an elegant biophysical mechanism: the bacteria remodel the membrane architecture to escape the very process that would have killed them.”

This discovery represents a shift in understanding how mycobacteria survive. Prior research largely focused on bacterial proteins that disrupt immune function. This study highlights the importance of lipids – fatty molecules – released by the bacteria, demonstrating that introducing these lipids into host cell membranes is enough to impair the immune response.

Researchers found that these extracellular vesicles don’t just protect the infected cell. They can also weaken nearby immune cells, even before those cells encounter the bacteria.

What’s Next?

The findings suggest several potential avenues for future treatment development. Scientists could potentially target the proteins responsible for producing these bacterial vesicles, or explore methods to counteract the membrane-stiffening effects. Blocking this process could restore the ability of immune cells to effectively eliminate the infection.

“Now that we understand how the bacteria protect themselves, we can start looking for ways to stop them,” Panda said. “If we can block the bacteria from stiffening those membranes, our immune cells might be able to do their job and stop the infection.”

Frequently Asked Questions

What are extracellular vesicles?

Extracellular vesicles are tiny packages released by mycobacteria that fuse with the membranes of immune cells.

How do mycobacteria use lipids to survive?

Mycobacteria release lipids that make the membranes of immune cells more rigid, preventing the fusion of phagosomes and lysosomes, and thus avoiding destruction.

Is this survival mechanism unique to tuberculosis?

The researchers observed similar effects in Klebsiella pneumoniae and Staphylococcus aureus, suggesting this strategy may be used by other pathogens.

How might understanding this mechanism change the way we approach treating tuberculosis and other bacterial infections?